共 30 条
- [21] A Case of Rapidly Progressive Interstitial Pneumonia in Association with Amyopathic Dermatomyositis with Elevated Titers of Anti-MDA-5 Antibody, Successfully Treated with Rituximab in Addition to Standard Immunosuppressive Therapy AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
- [22] Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Rapidly Progressing Interstitial Lung Disease Successfully Treated by Initiation of Combined Immunosuppressive Therapy Plus Plasma Exchange and Subsequently Switching Tacrolimus to Tofacitinib INTERNAL MEDICINE, 2024, 63 (18) : 2571 - 2578
- [26] Anti-nuclear matrix protein 2 antibody-associated juvenile dermatomyositis with gastrointestinal perforations was successfully treated with traditional therapeutic drugs combined with vedolizumab: a case report after a long-term follow-up and a review of the literature FRONTIERS IN PEDIATRICS, 2025, 12
- [27] Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis JOURNAL OF DERMATOLOGY, 2020, 47 (05): : 483 - 489
- [29] Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis ARTHRITIS & RHEUMATOLOGY, 2020, 72 (03) : 488 - 498
- [30] Subtherapeutic Infliximab Trough Levels and Complete Mucosal Healing Are Associated With Sustained Clinical Remission After Infliximab Cessation in Paediatric-onset Crohn's Disease Patients Treated With Combined Immunosuppressive Therapy JOURNAL OF CROHNS & COLITIS, 2018, 12 (06): : 644 - 652